Taizhou city in East China's Jiangsu province has moved to further boost its cooperation with the world's leading intergovernmental organization for research, training and technology transfer in the field of life sciences and biotechnology.
On March 31, Zhang Kun, vice-mayor of Taizhou and secretary of the Party working committee of the Taizhou Medical High-tech Zone, met with a delegation led by Lawrence Banks, director-general of International Center for Genetic Engineering and Biotechnology, or ICGEB.
Zhang thanked the center for its long-term concern and support for the construction and development of China Medical City, the core area for the development of Taizhou's pharmaceutical industry.
He added that since ICGEB's first regional research center had settled in China Medical City, both sides had achieved great results in international cooperation, exchanges and the incubation of sci-tech achievements.
For his part, Banks said that the International Centre for Genetic Engineering and Biotechnology China Regional Research Centre, or ICGEB China RRC, had made significant achievements in promoting international scientific and technological exchanges over the past five years.
He added that the ICGEB would continue to strengthen its cooperation with China and strongly support dialogue between ICGEB China RRC and ICGEB member countries.
During the event, Yang Yili, director of ICGEB China RRC and Banks signed an agreement to build a laboratory in Trieste in Italy for ICGEB China RRC.
Lawrence Banks (R) and Yang Yili sign the agreement to build a laboratory for ICGEB China RRC. [Photo/WeChat account: weigg6666]
Banks also signed an agreement for a project to develop an agent to treat leiomyoma tumors, also known as fibroids, with Peng Fuzhong, chairman of Jiangsu Huatai vaccine Engineering Technology Research.
